Lifeward (NASDAQ:LFWD – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($1.46) EPS for the quarter, missing analysts’ consensus estimates of ($1.39) by ($0.07), FiscalAI reports. Lifeward had a negative return on equity of 243.14% and a negative net margin of 123.66%.The business had revenue of $6.62 million during the quarter, compared to analysts’ expectations of $6.53 million.
Lifeward Price Performance
Shares of Lifeward stock traded down $0.44 during trading on Friday, reaching $7.45. 16,937 shares of the stock traded hands, compared to its average volume of 6,192. The company has a market capitalization of $21.08 million, a price-to-earnings ratio of -0.38 and a beta of 0.38. The business has a fifty day simple moving average of $7.43 and a two-hundred day simple moving average of $6.99. The company has a debt-to-equity ratio of 1.16, a current ratio of 2.40 and a quick ratio of 1.82. Lifeward has a 52-week low of $4.14 and a 52-week high of $10.56.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on LFWD shares. Weiss Ratings raised shares of Lifeward from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 3rd. Zacks Research raised shares of Lifeward from a “strong sell” rating to a “hold” rating in a report on Monday, July 27th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $10.00.
Institutional Investors Weigh In On Lifeward
Hedge funds have recently made changes to their positions in the company. Citadel Advisors LLC boosted its stake in Lifeward by 1,271.8% during the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after buying an additional 198,406 shares during the last quarter. Jane Street Group LLC grew its holdings in Lifeward by 77.3% during the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after buying an additional 29,927 shares in the last quarter. Virtu Financial LLC grew its holdings in Lifeward by 158.0% during the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after buying an additional 37,037 shares in the last quarter. Finally, HRT Financial LP increased its stake in Lifeward by 149.7% in the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after acquiring an additional 29,423 shares during the last quarter. 26.76% of the stock is currently owned by hedge funds and other institutional investors.
Lifeward Company Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Stories
- Five stocks we like better than Lifeward
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.
